Life science consultancy Indegene has acquired market-access advisory Medical Marketing Economics (MME) for $10 million, as it seeks to bolster its biopharma pricing and reimbursement capabilities.

MME and its team of 40 people, spread between Montclair, NJ, and Oxford, MS, will continue to operate as a standalone business. A source confirmed that the company anticipates hiring additional talent. 

“MME brings proven PRMA [pricing, reimbursement and market-access] capabilities that complement our co-commercialization solution,” Manish Gupta, Indegene co-founder and CEO, said in a statement.

Jack Mycka, MME global president and CEO, will report to Indegene co-founder and EVP Gaurav Kapoor, based in Princeton, NJ. 

The purchase marks Indegene’s first acquisition since raising $200 million from private equity firms Carlyle Group and Brighton Park Capital this year. Given that capital infusion, Indegene plans to continue expanding through acquisitions “in coming months,” Gupta said in a recent interview.

Indigene’s earlier acquisitions have included U.K.-based DT Associates, which specializes in digital transformation and customer experience.